BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18815046)

  • 1. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.
    Needham M; Corbett A; Day T; Christiansen F; Fabian V; Mastaglia FL
    J Clin Neurosci; 2008 Dec; 15(12):1350-3. PubMed ID: 18815046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
    Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
    Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.
    Needham M; James I; Corbett A; Day T; Christiansen F; Phillips B; Mastaglia FL
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1056-60. PubMed ID: 18258695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sporadic inclusion body myositis in Japan].
    Aoki M; Suzuki N
    Nihon Rinsho; 2012 May; 70(5):895-906. PubMed ID: 22620019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
    Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
    Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota.
    Wilson FC; Ytterberg SR; St Sauver JL; Reed AM
    J Rheumatol; 2008 Mar; 35(3):445-7. PubMed ID: 18203321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.
    Scott AP; Laing NG; Mastaglia F; Needham M; Walter MC; Dalakas MC; Allcock RJ
    J Neuroimmunol; 2011 Jun; 235(1-2):77-83. PubMed ID: 21543121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of inclusion-body myositis.
    Needham M; Mastaglia FL; Garlepp MJ
    Muscle Nerve; 2007 May; 35(5):549-61. PubMed ID: 17366591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisal.
    Needham M; Hooper A; James I; van Bockxmeer F; Corbett A; Day T; Garlepp MJ; Mastaglia FL
    Neuromuscul Disord; 2008 Feb; 18(2):150-2. PubMed ID: 18060780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.
    Mastaglia FL
    Acta Myol; 2009 Oct; 28(2):66-71. PubMed ID: 20128139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study.
    Dobloug GC; Antal EA; Sveberg L; Garen T; Bitter H; Stjärne J; Grøvle L; Gran JT; Molberg Ø
    Eur J Neurol; 2015 Apr; 22(4):672-e41. PubMed ID: 25530508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes.
    Mastaglia F; Price P; Walters S; Fabian V; Miller J; Zilko P
    Neuromuscul Disord; 2006 Nov; 16(11):754-8. PubMed ID: 16934978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and classification of sporadic inclusion body myositis (sIBM).
    Catalán M; Selva-O'Callaghan A; Grau JM
    Autoimmun Rev; 2014; 13(4-5):363-6. PubMed ID: 24424185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.
    Needham M; Mastaglia FL
    Lancet Neurol; 2007 Jul; 6(7):620-31. PubMed ID: 17582362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)].
    Suzuki N; Tateyama M; Warita H; Izumi R; Nishino I; Aoki M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):964-6. PubMed ID: 22277440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients.
    Santorelli FM; Sciacco M; Tanji K; Shanske S; Vu TH; Golzi V; Griggs RC; Mendell JR; Hays AP; Bertorini TE; Pestronk A; Bonilla E; DiMauro S
    Ann Neurol; 1996 Jun; 39(6):789-95. PubMed ID: 8651651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1.
    Scott AP; Allcock RJ; Mastaglia F; Nishino I; Nonaka I; Laing N
    Neuromuscul Disord; 2006 May; 16(5):311-5. PubMed ID: 16564169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inclusion body myositis].
    Suzuki N; Aoki M
    Brain Nerve; 2011 Nov; 63(11):1205-15. PubMed ID: 22068473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis.
    Scott AP; Laing NG; Mastaglia F; Dalakas M; Needham M; Allcock RJ
    J Neuroimmunol; 2012 Sep; 250(1-2):66-70. PubMed ID: 22732452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.
    Cox FM; Titulaer MJ; Sont JK; Wintzen AR; Verschuuren JJ; Badrising UA
    Brain; 2011 Nov; 134(Pt 11):3167-75. PubMed ID: 21908393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.